Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/27/2013 | CN103415521A 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
11/27/2013 | CN103415519A 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
11/27/2013 | CN103415291A Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone by using a dosing algorithm to provide analgesia |
11/27/2013 | CN103415289A Pro-neurogenic compounds |
11/27/2013 | CN103415286A Compounds and methods for treating pain |
11/27/2013 | CN103409511A Diagnosis and treatment of Alzheimer's disease |
11/27/2013 | CN103409306A Health fleece-flower root wine |
11/27/2013 | CN103409295A Health-care wine for tonifying kidney and production method thereof |
11/27/2013 | CN103408656A Morphine/heroin vaccine formed by covalently binding hapten and carrier, and application thereof |
11/27/2013 | CN103408612A Phenanthrene and dihydrophenanthrene compounds and application thereof |
11/27/2013 | CN103408504A Clozapine crystal compound, nanometer rapidly disintegrating tablet and preparation methods of clozapine crystal compound, a nanometer rapidly disintegrating tablet |
11/27/2013 | CN103408501A Benzyl pyrimidine derivatives, and preparation method and medical application thereof |
11/27/2013 | CN103405761A Liquid vaccines for multiple meningococcal serogroups |
11/27/2013 | CN103405751A Composition with cell repairing function and preparation method and application thereof |
11/27/2013 | CN103405740A Chinese medicine composition for external use and preparation method thereof |
11/27/2013 | CN103405736A Medicine for treatment of blood vacuity headache |
11/27/2013 | CN103405727A Medicinal liquor for activating blood circulation and relieving headache |
11/27/2013 | CN103405726A Formula of great soup for soothing liver, dispelling depression, detoxifying and nourishing spirit |
11/27/2013 | CN103405724A Traditional Chinese medicine composition and preparation method thereof |
11/27/2013 | CN103405719A Medicament for treatment of depression |
11/27/2013 | CN103405716A Herbal decoction for treating insomnia |
11/27/2013 | CN103405711A Mind-calming mixture for treating hysteria |
11/27/2013 | CN103405707A Chinese medicine preparation for regulating ti-flowing for strengthening spleen and eliminating dampness and phlegm |
11/27/2013 | CN103405685A Traditional Chinese medicine composition for treating cerebrovascular disease sequelae |
11/27/2013 | CN103405684A Drug for treating hemiplegia and preparation method thereof |
11/27/2013 | CN103405660A Compound medicine for treating headache |
11/27/2013 | CN103405651A Preparation method of ointment for ulnar nerve injury |
11/27/2013 | CN103405650A External medicine for nerve injury caused by wrist traumas |
11/27/2013 | CN103405649A External pharmaceutical composition for recovery after nervus peroneus communis injury |
11/27/2013 | CN103405648A External care substance for ulnar nerve injury |
11/27/2013 | CN103405637A Drug for treating neurosis and preparation method thereof |
11/27/2013 | CN103405636A Drug for treating insomnia and preparation method thereof |
11/27/2013 | CN103405616A TCM (Traditional Chinese Medicine) composition for invigorating kidney and strengthening Yang and preparation and detection methods of TCM composition |
11/27/2013 | CN103405611A Cephalocathartic pain relieving eyesight improving pills |
11/27/2013 | CN103405579A Preparation method of ointment for median nerve injury |
11/27/2013 | CN103405553A Solid-gel ultra-refreshing fragrant refreshing agent and preparation method thereof |
11/27/2013 | CN103405550A Compound essential oil capable of relieving tension and pressure |
11/27/2013 | CN103405549A Compound essential oil for enhancing happy feeling |
11/27/2013 | CN103405533A Preparation method of healthcare medicament with brain nourishing function |
11/27/2013 | CN103405514A Antihypertensive pillow with medicine inside |
11/27/2013 | CN103405502A Drug for treating hemiplegia and preparation method thereof |
11/27/2013 | CN103405498A Compound lipid-lowering pills |
11/27/2013 | CN103405468A Use of low-molecular weight oligomannuronate in preparation of drug or health care product for preventing or treating Parkinson's disease |
11/27/2013 | CN103405460A Therapeutic agent for meniere |
11/27/2013 | CN103405441A Tension headache treatment preparation |
11/27/2013 | CN103405431A Opioid and opioid-like compounds and uses thereof |
11/27/2013 | CN103405408A Application of chrysin in preparation of medicines for treating cerebral arterial thrombosis |
11/27/2013 | CN103405404A Novel use of dimethyloxalglycine and mesenchymal stem cell separation method |
11/27/2013 | CN103405400A Levosulpiride injection and preparation method thereof |
11/27/2013 | CN103405394A Metoprolol tartrate sustained release tablet and preparation method thereof |
11/27/2013 | CN103405287A Natural hole branch inserting method for preventing and treating domestic animals diseases |
11/27/2013 | CN103405088A Health care mat for infants and manufacturing method thereof |
11/27/2013 | CN103007229B Medicine for treating neurogenic bladder |
11/27/2013 | CN102793772B Plant essential oil capable of energizing and restoring consciousness |
11/27/2013 | CN102784288B Traditional Chinese medicine formula for treating insomnia |
11/27/2013 | CN102727823B Medicine for postoperative rehabilitation of cerebral hemorrhage |
11/27/2013 | CN102698082B Concha haliotidis Chinese medicinal preparation for treating dizziness and preparation method thereof |
11/27/2013 | CN102579969B Traditional Chinese medicinal preparation for treating anxiety disorder |
11/27/2013 | CN102579849B Sodium valproate and preparation process thereof |
11/27/2013 | CN102440974B Olanzapine orally disintegrating pharmaceutical composition |
11/27/2013 | CN102335227B Medicine for treating senile dementia and preparation method thereof |
11/27/2013 | CN102329325B Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors |
11/27/2013 | CN102311447B Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor |
11/27/2013 | CN102283920B Medicinal composition for treating parkinson disease as well as preparation method and application thereof |
11/27/2013 | CN102216283B Quinazoline derivatives as NK3 receptor antagonists |
11/27/2013 | CN101947205B Novel galanthamine sustained-release preparation and preparation method thereof |
11/27/2013 | CN101918362B 吡啶衍生物 Pyridine derivatives |
11/27/2013 | CN101511835B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
11/27/2013 | CN101374513B Use of benzo-fused heterocycle sulfamide derivatives for preparing drugs of treatment of epilepsy |
11/26/2013 | US8592580 Substituted triazinone derivatives |
11/26/2013 | US8592433 Compounds and compositions as protein kinase inhibitors |
11/26/2013 | US8592422 Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors |
11/26/2013 | US8592420 Method of treating an anxiety disorder |
11/26/2013 | US8592407 Pyrrolo[2,1-c][1,4] benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof |
11/26/2013 | US8592395 Therapeutic compounds |
11/26/2013 | US8592379 Metastin derivative and use thereof |
11/26/2013 | US8591950 Hydrogel implants with varying degrees of crosslinking |
11/26/2013 | US8591935 Methods and compositions for treating pain comprising a statin |
11/26/2013 | US8591894 Humanized antibodies that sequester amyloid beta peptide |
11/26/2013 | CA2612738C Solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
11/26/2013 | CA2610361C Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control |
11/26/2013 | CA2378562C Method for producing oligopolysaccharides |
11/26/2013 | CA2279231C Activity dependent neurotrophic factor iii (adnf iii) |
11/21/2013 | WO2013173730A2 Novel therapeutic uses of mu-opiate receptor peptides |
11/21/2013 | WO2013173707A1 Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide |
11/21/2013 | WO2013173608A1 Compositions and methods for modulating mecp2 expression |
11/21/2013 | WO2013173601A1 Compositions and methods for modulating bdnf expression |
11/21/2013 | WO2013173370A1 Small molecule inhibitors of rna binding motif (rbm) proteins for the treatment of acute cellular injury |
11/21/2013 | WO2013172999A1 Pharmaceutical compositions for the delivery of substantially water-insoluble drugs |
11/21/2013 | WO2013172944A1 Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells |
11/21/2013 | WO2013172872A1 Pyrimidine diamine derivatives as inhibitors of cytosolic hsp90 |
11/21/2013 | WO2013172537A1 Pharmaceutical composition for treating or preventing neurological disorders caused by alcohol exposure during pregnancy, containing metformin and/or thymoquinone |
11/21/2013 | WO2013172436A1 Novel glycosylated compound of crocin, method for producing same, and use for same |
11/21/2013 | WO2013172297A1 Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative |
11/21/2013 | WO2013172087A1 Composition provided with nitric oxide production-inhibiting activity |
11/21/2013 | WO2013171712A1 Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease |
11/21/2013 | WO2013171345A1 Tri-substituted glycerol compounds for use in the treatment of clinically isolated syndrome and/or multiple sclerosis |
11/21/2013 | WO2013171233A1 Use of cacybp/sip in the treatment and diagnosis of alzheimer's disease |
11/21/2013 | WO2013170972A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an anticonvulsant |
11/21/2013 | WO2013170971A1 Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a nsar |